• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Aptamers Market Technology Trend Analysis - Global Forecasts to 2018 - Product Image

Aptamers Market Technology Trend Analysis - Global Forecasts to 2018

  • ID: 2587211
  • July 2013
  • Region: Global
  • 171 Pages
  • Markets and Markets

FEATURED COMPANIES

  • AM Biotechnologies, Llc
  • Aptamer Sciences Inc
  • Aptusbiotech
  • Cd Genomics
  • Ophthotech Corporation
  • Regado Biosciences, Inc
  • MORE

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018

Aptamers is an emerging market sector, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018. This research report categorizes the global aptamers market into geography, applications, and aptamer type. The applications market is further broken down by geography, with exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2018.

Aptamers existed alongside antibodies for two decades, but their market potential was not utilized to even a fraction of the same degree. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, READ MORE >

FEATURED COMPANIES

  • AM Biotechnologies, Llc
  • Aptamer Sciences Inc
  • Aptusbiotech
  • Cd Genomics
  • Ophthotech Corporation
  • Regado Biosciences, Inc
  • MORE

1 Introduction
1.1 Logical Assumptions In This Study Based On Reliable Sources
1.2 Key Take-Aways
1.3 Report Scope
1.4 Research Methodology
1.5 Key Data Points From Secondary And Primary Sources

2 Executive Summary

3 Aptamers – Technology Landscape Analysis
3.1 Technology Overview
3.2 History & Milestones Of Aptamers
3.3 Aptamers Vs Antibodies
3.4 Aptamer Types
3.4.1 Nucleic Acid Aptamers
3.4.2 Peptide Aptamers
3.5 Aptamer Synthesis & Modifications
3.6 Applications
3.6.1 Therapeutics
3.6.1.1 Different Targets Of Therapeutic Interest
3.6.2 Diagnostics
3.6.3 Biosensors
3.6.4 Drug Discovery
3.6.5 Biomarker Discovery
3.6.6 Research Applications
3.6.6.1 Reagents & Assays
3.6.6.2 Flow Cytometry
3.6.6.3 Mass Spectrometry
3.6.6.4 Western Blotting
3.7 Technology Value Chain Analysis
3.8 Aptamers – Technology Innovations And Products With Applications

4 Aptamers – Market Landscape Analysis
4.1 Aptamers Market Segmentation
4.2 Aptamers Technology - Global Impact
4.3 Market Forecast (2013 - 2018) – Overview
4.4 Global Aptamers Market Revenue Forecast (2013-2018)
4.4.1 Global Aptamers Market Revenue – By Geography
4.4.1.1 North America
4.4.1.2 Europe
4.4.1.3 Asia Pacific
4.4.1.4 Rest Of The World
4.4.2 Global Aptamers Market Share – By Geography
4.4.2.1 North America
4.4.2.2 Europe
4.4.2.3 Asia Pacific
4.4.2.4 Rest Of The World
4.4.3 Global Aptamers Market Revenue – By Application Segments
4.4.3.1 Global Aptamers Market Share – By Segments
4.4.3.2 Therapeutic Aptamers Market – By Region
4.4.3.3 Diagnostics Aptamers Market – By Region
4.4.3.4 Biosensors Aptamers Market – By Region
4.4.3.5 Drug Discovery Aptamers Market – By Region
4.4.3.6 Aptamers Biomarker Discovery Market – By Region
4.4.3.7 Aptamers Research Applications Market – By Region
4.4.4 Global Aptamers Market Revenue – By Aptamer Type
4.4.4.1 Nucleic Acid Aptamer Market – By Region
4.4.4.2 Peptide Aptamer Market – By Region
4.4.4.3 Nucleic Acid And Peptide Aptamers Market Share – By Region
4.5 Market Dynamics
4.5.1 Drivers - Explanation
4.5.1.1 Impact Analysis By Timeline
4.5.2 Restraints – Explanation
4.5.2.1 Impact Analysis By Timeline
4.6 SWOT Analysis
4.7 Porter’s Five Forces Analysis

5 Technology Investment Potential
5.1 Investment Climate Assessment
5.2 Investor Network
5.3 Some Funds And Investments On Aptamers
5.4 Some Funds And Investments From Nih – By Fiscal Year
5.5 Some Funds And Investments From Nih – By Its Associated Institutes/Centers (FY 2008-2013)
5.6 Insights On Current And Future Tech-Investment Trends

6 Aptamers – Technology Adoption And Development Potential
6.1 Geographic Adoption And Development Potential - Overview
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Row – Selected Countries
6.6 Demand Side Analysis
6.7 Technology Roadmap

7 Aptamers Competitive Landscape
7.1 Competitive Landscape Analysis
7.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2009 – 2013)
7.3 Startups And Spinoff’s Based On Aptamers Technology
7.4 Clinical Trials Of Aptamers – By Different Properties (Anti-Coagulant Aptamers, Anti-Angiogenic Aptamers, Anti-Oncogenic Aptamers, Anti-Diabetic Aptamers)

7.4.1 Apamer Based Drugs In Clinical Trials

8 Intellectual Property And Research Strength Analysis
8.1 Selected Aptamer And Selex Patents
8.2 IP Strength Analysis Of Aptamers
8.3 Proprietary Technologies Based On Aptamers

9 Analyst Insights And Recommendations
9.1 Analyst Insights
9.2 Strategic Recommendations For Technology & Business Investors
9.3 Open Opportunity Invitations In The Field For Business Development

10 Company Profiles (Slide No- 134)
10.1 AM Biotechnologies, Llc
10.2 Aptagen, LIC
10.3 Aptamer Sciences Inc.
10.4 Aptamer Solutions Ltd
10.5 Aptares AG
10.6 Base Pair Biotechnologies
10.7 Integrated Dna Technologies, Inc
10.8 Neoventures Biotechnology Inc.
10.9 NOXXON Pharma AG
10.10 OTC Biotech
10.11 Somalogic, Inc.
10.12 Trilink Biotechnologies, Inc.
10.13 Vivonics
10.14 Pfizer
10.15 Aptamatrix, Inc.
10.16 Aptusbiotech
10.17 Bioapter S.L.
10.18 Cd Genomics
10.19 Lucerna, Inc.
10.20 Ophthotech Corporation
10.21 Regado Biosciences, Inc.

List Of Tables ( 14 Tables)

Table 1 Global Aptamers Market, 2013 - 2018 ($Million)
Table 2 Global Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 3 Global Aptamers Market Revenue, By Application Segment, 2013 - 2018 ($Million)
Table 4 Therapeutic Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 5 Diagnostics Aptamers Market, By Region, 2013 - 2018 ($Million)
Table 6 Biosensor Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 7 Drug Discovery Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 8 Aptamers Biomarker Discovery Market, By Geography, 2013 - 2018 ($Million)
Table 9 Aptamers Research Applications Market, By Geography, 2013 - 2018 ($Million)
Table 10 Global Aptamers Market, By Type, 2013 - 2018 ($Million)
Table 11 Nucleic Acid Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 12 Peptide Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 13 Funds By Nih & Associated Centers 2008-2013 ($Million)
Table 14 Projects And Funds By Nih & Associated Centers 2008-2013 ($Million)

List Of Figures (29 Figures)

Figure 1 Global Market Of Aptamers 2013 – 2018 ($Million)
Figure 2 Global Market Of Aptamers 2013 – 2018 ($Million)
Figure 3 Global Aptamers Market Revenue, By Geography, 2013 – 2018 ($Million)
Figure 4 Global Aptamers Market Share By Geography, 2013
Figure 5 Global Aptamers Market Share By Geography, 2018
Figure 6 Global Aptamers Technology Market Revenue, By Applications, 2013 – 2018 ($Million)
Figure 7 Global Aptamers Technology Market Share, By Applications, 2013 – 2018
Figure 8 Global Aptamers Market Share By Segments, 2013
Figure 9 Global Aptamers Market Share By Segments, 2018
Figure 10 Therapeutic Aptamers Market, By Region, 2013 – 2018 ($Million)
Figure 11 Therapeutic Aptamer Market By Region, 2013
Figure 12 Therapeutic Aptamer Market By Region, 2018
Figure 13 Diagnostics Aptamers Market, By Region, 2013 – 2018 ($Million)
Figure 14 Diagnostics Aptamers Market By Region, 2013
Figure 15 Diagnostics Aptamers Market By Region, 2018
Figure 16 Biosensor Aptamers Market, By Region, 2013 – 2018 ($Million)
Figure 17 Biosensor Aptamers Market By Region, 2013
Figure 18 Biosensor Aptamers Market By Region, 2018
Figure 19 Drug Discovery Aptamers Market, By Region, 2013 – 2018 ($Million)
Figure 20 Drug Discovery Aptamers Market By Region, 2013 80
Figure 21 Drug Discovery Aptamers Market By Region, 2018 80
Figure 22 Aptamers Biomarker Discovery Market, By Region, 2013 – 2018 ($Million)
Figure 23 Aptamers Biomarker Discovery Market By Region, 2013
Figure 24 Aptamers Biomarker Discovery Market By Region, 2018
Figure 25 Aptamers Research Applications Market, By Region, 2013 – 2018 ($Million)
Figure 26 Aptamers Research Applications Market By Region, 2013
Figure 27 Aptamers Research Applications Market By Region, 2018
Figure 28 Global Aptamers Market, Nucleic Acid Aptamer, 2013 – 2018 ($Million)
Figure 29 Global Aptamers Market, Peptide Aptamer, 2013 – 2018 ($Million)

FEATURED COMPANIES

  • AM Biotechnologies, Llc
  • Aptamer Sciences Inc
  • Aptusbiotech
  • Cd Genomics
  • Ophthotech Corporation
  • Regado Biosciences, Inc
  • MORE

The global aptamers market is anticipated to reach $2.1 billion by 2018 growing at a CAGR of 49.24%. The aptamers market is divided by geography (North America, Europe, Asia-Pacific and Rest of the World), application segments (therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications) and aptamer type (Nucleic acid aptamers and Peptide aptamers). Further each application segment and the aptamer type is broken down by geography, with exhaustive revenue analysis for the entire forecast period. Of the above mentioned application segments, research applications is the largest revenue segment; however, biomarker discovery and diagnostics will be the fastest-growing segment.

The potential growth of the market is attributed to future diagnostics, drug discovery and research applications. The future approval of a few diagnostic tests specifically for infectious diseases and a couple of drugs in the market will greatly propel the market. The global market for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis. The market will experience continuous improvements in aptamer synthesis and its applicability in drug discovery and routine research. The market is witnessing a trend toward development of personalized medicine and point-of-care diagnostic tests. Additionally, the demand for safe and cost-effective drugs for treatment of cancer (which can be fulfilled by aptamer therapeutics), will remarkably fuel market growth.

North America is a significant contributor to the market, followed by Europe, due to the presence of technology providers and better R&D facilities. The new markets that are expected to grow at a brisk pace are emerging economics such as China, India, Japan and other regions of Asia-Pacific and untapped markets of Europe due to their growing GDP, healthcare costs, and rising demand for safe and cost-effective diagnostics and therapeutics.

Key players in this market are AM Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.), Aptamer Sciences Inc. (South Korea), Aptamer Solutions Ltd (U.K.), Base Pair Biotechnologies (U.S.), Bioapter S.L. (Spain), Integrated Biotechnologies, Inc. (U.S.), NOXXON Pharma AG (Germany), OTC Biotech (U.S.), Regado Biosciences, Inc. (U.S.), Somalogic, Inc. (U.S.), and TriLink BioTechnologies, Inc. (U.S.).

- AM Biotechnologies, Llc
- Aptagen, LIC
- Aptamatrix, Inc
- Aptamer Sciences Inc
- Aptamer Solutions Ltd
- Aptares AG
- Aptusbiotech
- Base Pair Biotechnologies
- Bioapter SL
- Cd Genomics
- Integrated Dna Technologies, Inc
- Lucerna, Inc
- NOXXON Pharma AG
- Neoventures Biotechnology Inc
- OTC Biotech
- Ophthotech Corporation
- Pfizer
- Regado Biosciences, Inc
- Somalogic, Inc
- Trilink Biotechnologies, Inc
- Vivonics

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos